Cleared Traditional

K121816 - SENSUS ELECTRODE

K121816 is an FDA 510(k) clearance for SENSUS ELECTRODE, manufactured by Neurometrix, Inc.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 159-day FDA review.

K121816 · Neurometrix, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
159d
Days
Class 2
Risk

K121816 is an FDA 510(k) clearance for the SENSUS ELECTRODE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Neurometrix, Inc. (Waltham, US). The FDA issued a Cleared decision on November 26, 2012 after a review of 159 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurometrix, Inc. devices

FDA 510(k) Submission Details - K121816

510(k) Number K121816 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2012
Decision Date November 26, 2012
Days to Decision 159 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 148d · This submission: 159d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 213
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K121816.
GARMENT ELECTRODES
K141076 · Shenzhen Dongdixin Technology Co., Ltd. · Nov 2014
DYNATRON PELTIER THERMOSTIM PROBE
K132057 · Dynatronics Corp. · Jan 2014
PMT TRUSCAN SURFACE ELECTRODE
K122376 · Pmt Corp. · Dec 2012
LONG LIFE PADTM
K120516 · Omron Healthcare, Inc. · May 2012
NEUROTECH RECOVERY
K112934 · Bio-Medical Research, Ltd. · Jan 2012
LIFECARE CONDUCTIVE GARMENTS
K103719 · Everyway Medical Instruments Co.,Ltd · Aug 2011